Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 61.47934 on 06-02-2026 at 19:20:03
Change 0.00 0%
Buy 0.00
Sell 0.00
Last Trade: Unknown 313.00 at 61.42001
Day's Volume: 80,189
Last Close: 61.47934
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 30.61 - 63.54381
Market Capitalisation: -
VWAP: 61.42311
Shares in Issue: 430.70m

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 313 61.42001 OTC Trade
18:28:39 - 06-Feb-26
Unknown* 66 61.40 OTC Trade
17:53:14 - 06-Feb-26
Unknown* 629 61.57859 OTC Trade
17:39:38 - 06-Feb-26
Unknown* 3,782 61.5222 OTC Trade
17:39:38 - 06-Feb-26
Unknown* 2 61.61616 OTC Trade
17:39:38 - 06-Feb-26
Unknown* 152 61.47934 SI Trade
Negotiated Trade
17:33:06 - 06-Feb-26
Unknown* 4,084 61.40 OTC Trade
17:23:16 - 06-Feb-26
Unknown* 41 61.58657 SI Trade
Negotiated Trade
17:22:45 - 06-Feb-26
Unknown* 5,804 61.48672 OTC Trade
17:08:09 - 06-Feb-26
Unknown* 450 61.61938 OTC Trade
17:08:05 - 06-Feb-26
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Feb 2026 (Fri) 61.47934 61.47934 61.47934 61.47934 80,189
5th Feb 2026 (Thu) 60.88523 60.88523 60.88523 60.88523 125,895
4th Feb 2026 (Wed) 60.4596 60.4596 60.4596 60.4596 540,615
3rd Feb 2026 (Tue) 60.07 60.07 60.07 60.07 107,644
2nd Feb 2026 (Mon) 60.95297 60.95297 60.95297 60.95297 276,086
30th Jan 2026 (Fri) 61.37333 61.37333 61.37333 61.37333 361,085
29th Jan 2026 (Thu) 61.23852 61.23852 61.23852 61.23852 122,241
28th Jan 2026 (Wed) 61.9039 61.9039 61.9039 61.9039 460,794
27th Jan 2026 (Tue) 63.54381 63.54381 63.54381 63.54381 110,645
26th Jan 2026 (Mon) 62.39111 62.39111 62.39111 62.39111 618,828
23rd Jan 2026 (Fri) 62.39443 62.39443 62.39443 62.39443 128,176
22nd Jan 2026 (Thu) 62.0367 62.0367 62.0367 62.0367 47,081
21st Jan 2026 (Wed) 62.00 62.00 62.00 62.00 117,597
20th Jan 2026 (Tue) 60.78614 60.78614 60.78614 60.78614 164,597
19th Jan 2026 (Mon) 61.13043 61.13043 61.13043 61.13043 108,360
16th Jan 2026 (Fri) 62.08 62.08 62.08 62.08 162,823
15th Jan 2026 (Thu) 60.88 60.88 60.88 60.88 89,584
14th Jan 2026 (Wed) 60.06 60.06 60.06 60.06 117,211
13th Jan 2026 (Tue) 59.22 59.22 59.22 59.22 59,057
12th Jan 2026 (Mon) 59.90 59.90 59.90 59.90 27,941
9th Jan 2026 (Fri) 60.56 60.56 60.56 60.56 479,547
8th Jan 2026 (Thu) 60.42667 60.42667 60.42667 60.42667 198,649
7th Jan 2026 (Wed) 60.56 60.56 60.56 60.56 67,999
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value10,369.75
Change60.53

Login to your account

Forgot Password?

Not Registered